Markets
paper Chinese yuan in piles
(Shutterstock)

The market wants more from China

The stock rally continued when China’s onshore market reopened, but traders were disappointed at the lack of further policies to save China’s sluggish economy

China’s market had an epic rally after China’s central bank unveiled a slew of monetary stimulus measures in September. 

A big question remained, though: how long will it last? We may have gotten some clues as the market reopened on Tuesday after a seven-day National Day holiday from October 1 to 7, as the policy-driven rally seemed to have lost some momentum. 

The CSI 300, which tracks the top 300 stocks traded on the Shanghai Stock Exchange and the Shenzhen Stock Exchange, surged nearly 11% during the market open on Tuesday. But the index eased some gains throughout the day to finish 6.1% up.

Meanwhile, Hong Kong’s benchmark index, Hang Seng, slumped 5.6% on Tuesday, wiping out all gains during the National Day holiday (the Hong Kong stock exchange was closed only on October 1).

The decline was partly due to a disappointing presser from China’s top economic planner. After late September’s stimulus — which included rate cuts, lower existing mortgage rates, lower required reserve ratio, and a 800-million-yuan liquidity support for the stock market — traders were expecting more details on fiscal stimulus from the government to get the economy back on track. That includes spending incentives, special bonds, and support for “new college graduates, migrant workers, the unemployed, elderly, and disabled,” analysts said.

But at its first post-holiday meeting, the National Development and Reform Commission (NDRC) “did not provide any more details around the shape and size of the fiscal support that has been announced,” Deutsche Bank analysts wrote in a note.

Wall Street was expecting somewhere between 2 trillion and 3 trillion yuan in fiscal packages. The NDRC, however, announced a modest 200 billion yuan (about $28.3 billion), 100 billion yuan of which was going to construction projects. 

Some China watchers said that the announcement wasn’t surprising, given how Chinese government agencies usually behave. NDRC’s main goal was likely not to meet the market where it was, but more to send a signal to top government officials about the intent to target the economy, notwithstanding concrete policies.

Still, the CSI 300 finished at another record high. ETFs that track China megacaps gained over 30% in the past month, outperforming the S&P 500.

The market vs. the economy

Broadly, analysts agree that the booming stock market doesn’t change the fundamentals of China’s economy, which has been on a downhill path since 2021. But degrees of optimism over the market rally differ. 

Goldman Sachs upgraded its call on Chinese offshore stocks (Chinese companies that trade in Hong Kong or the US) to overweight on October 7 and shifted its tactical preference from H-shares (that are traded in Hong Kong dollars) to A-shares (that are traded in Chinese yuan), saying in a note to clients that these stocks are more directly exposed to stock market stimulus and retail investors’ participation.

Indeed, the retail sentiment alone, independent of fiscal measures, was strong in China. State media reported a 4x to 6x surge in the number of new brokerage accounts, mostly from young people. ETF inflows and margin financing activities also rose. Shares of China’s brokerage software like Hithink Flush and East Money have more than doubled since September 23.

But others see the Chinese economy as a deeper problem. Adam Wolfe, emerging markets economist at Absolute Strategy Research, distinguished between the stimulus measures for the real economy and the stock market, calling the former “mostly incremental, small, and inconsequential,” while the latter was “new, unlimited, and significant.” 

Olivier d’Assier, Head of APAC, Investment Decision Research at SimCorp, said that China’s banking system is “teetering on the verge of collapse,” and the announced stimulus was not enough.

“It is $59 trillion in size and only $142 billion was announced to recapitalize it — compare this to a US banking system of $23.4 trillion, much better diversified than China’s, and where the Fed spent $475 billion to recapitalize it during the GFC,” he said.

“As for the market, this is a policy-driven rally. It won’t last and it won’t change the equation for investors — most of whom will not have bought at the bottom,” d’Assier added.

More Markets

See all Markets
markets

FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation

The Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 compounding, a day after Hims & Hers announced that it would sell copies ofNovo Nordisk’sWegovy pill.

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

Airlines rise, continuing their volatile 2026, as US-Iran talks may foreshadow some oil supply relief

Airline stocks are surging on Friday, as the market appears to be pricing in some medium-term oil pricing relief following talks between the US and Iran. Iranian officials referred to the meeting as “a good beginning.”

Shares of budget carriers, which have tighter margins and are more sensitive to fluctuations in fuel costs, are leading the surge. Frontier Airlines and Allegiant up more than 13%, while major airlines like United Airlines, American Airlines, and Delta Air Lines are also up at least 6%. JetBlue and Alaska Air are similarly up about 6%.

The market more broadly is rebounding on Friday, with the S&P 500 up 1.6% and bitcoin recovering some of this week’s losses.

Airlines have been volatile to start 2026 amid geopolitical tensions, varying annual forecasts, and the impact of winter storms.

markets

The AI supply chain is soaring thanks to Amazon’s capex budget

If tech companies are going to spend way more than expected on capex, well, that means other companies are poised to benefit from that massive spending spree.

Amazon’s plan for $200 billion in business investment this year was the exclamation point to end a reporting period that saw every Magnificent 7 hyperscaler that provides guidance offer a 2026 capex budget well above what Wall Street had anticipated.

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

markets

For memory chips, the “parabolic price hike” is continuing to ramp higher

The remarkable run-up in prices for memory chips continued into early February, analysts at Bernstein Research say, driven largely by data center demand from hyperscalers and cloud service providers (CSP).

Prices for NAND flash memory wafers — a type of memory used in devices, as it retains data even when powered down — soared 35% between the end of 2025 and February 2.

Spot prices for DRAM — ubiquitous short-term data storage chips — jumped about 28% in that period. But that massively understates the remarkable shift in pricing for what were long seen as commodity tech hardware inputs. DRAM prices are more than 2,000% over the last year, while NAND prices are up more than 600% in that period.

The ongoing momentum provides still more support for memory chip plays like Micron and Sandisk, which have been big market winners in recent months.

In a note published earlier this week, Bernstein Research analysts wrote:

“The parabolic price hike continued in Jan. Indicated price increase for 1QCY26 is much stronger than we expected and we hence see upside to our near term memory pricing projection. Unrelenting CSP demand remained the main driver. PC and Mobile demand hasn’t been destroyed yet because of lean inventory & pull-forward purchase. Going forward price hike is expected to continue but likely at a slower rate, as PC and Mobile demand should contract meaningfully this year. Price however may stay elevated throughout this year, supported by CSP demand.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.